Literature DB >> 17505705

Urinary and sexual manifestations of patients infected by HTLV-I.

Paulo Oliveira1, Néviton Matos de Castro, Edgar M Carvalho.   

Abstract

HTLV-I is considered to be a virus of low morbidity, since the principal diseases associated with this viral infection, HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T-cell leukemia/lymphoma (ATLL), are observed in less than 5% of infected individuals. Urinary symptoms are frequent in patients with myelopathy and consist principally of nocturia, frequency, urgency, and urinary incontinence; however, the importance of these dysfunctions and their correlation with myelopathy is still to be fully clarified. This review gives particular emphasis to the high frequency of urinary and sexual complaints not only in patients with myelopathy but also in individuals considered to be HTLV-I carriers. Detrusor overactivity and bladder-sphincter dyssynergia are the most common urodynamic findings. The fact that urinary complaints and urodynamic parameters reported in individuals considered to be carriers are similar to those detected in patients with myelopathy supports the hypothesis that urinary disorders may represent an oligosymptomatic form of HAM/TSP. Erectile dysfunction is frequently observed in HTLV-I-infected patients with or without myelopathy. Urinary tract infections are also highly prevalent in these patients. Despite the lack of an effective treatment for myelopathy, the use of anticholinergic drugs and phosphodiesterase type 5 (PDE5) inhibitors may improve urinary complaints and erectile dysfunction in these patients.

Entities:  

Mesh:

Year:  2007        PMID: 17505705     DOI: 10.1590/s1807-59322007000200015

Source DB:  PubMed          Journal:  Clinics (Sao Paulo)        ISSN: 1807-5932            Impact factor:   2.365


  15 in total

1.  Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection.

Authors:  Silvane Braga Santos; Paulo Oliveira; Tania Luna; Anselmo Souza; Márcia Nascimento; Isadora Siqueira; Davi Tanajura; André Luiz Muniz; Marshall J Glesby; Edgar M Carvalho
Journal:  J Med Virol       Date:  2012-11       Impact factor: 2.327

Review 2.  Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases.

Authors:  Denise Utsch Gonçalves; Fernando Augusto Proietti; João Gabriel Ramos Ribas; Marcelo Grossi Araújo; Sônia Regina Pinheiro; Antônio Carlos Guedes; Anna Bárbara F Carneiro-Proietti
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

3.  Prevalence of erectile dysfunction in HTLV-1-infected patients and its association with overactive bladder.

Authors:  Paulo Oliveira; Néviton M Castro; André L Muniz; Davi Tanajura; Julio C Brandão; Aurélia F Porto; Edgar M Carvalho
Journal:  Urology       Date:  2010-02-26       Impact factor: 2.649

4.  Clinical manifestations in individuals with recent diagnosis of HTLV type I infection.

Authors:  Shelene K W Poetker; Aurelia F Porto; Silvana P Giozza; Andre L Muniz; Marina F Caskey; Edgar M Carvalho; Marshall J Glesby
Journal:  J Clin Virol       Date:  2011-03-08       Impact factor: 3.168

5.  Neurological symptoms and signs in HTLV-1 patients with overactive bladder syndrome.

Authors:  Davi Tanajura Costa; André Luiz Muniz Alves dos Santos; Néviton Matos de Castro; Isadora Cristina de Siqueira; Edgar Marcelino de Carvalho Filho; Marshall Jay Glesby
Journal:  Arq Neuropsiquiatr       Date:  2012-04       Impact factor: 1.420

6.  Integrative and Multidisciplinary Care for People Living With Human T-Cell Lymphotropic Virus in Bahia, Brazil: 20 Years of Experience.

Authors:  Bernardo Galvão-Castro; Maria Fernanda Rios Grassi; Ana Verena Galvão-Castro; Aidê Nunes; Ana Karina Galvão-Barroso; Thessika Hialla Almeida Araújo; Regina Helena Rathsam-Pinheiro; Ceuci Lima Xavier Nunes; Adriele Ribeiro; Monique Lírio; Noilson Lázaro Gonçalves; Sônia Lúcia Rangel; Cristiane Maria Carvalho Costa Dias; Daniele Piai Ozores; Selena Márcia Dubois-Mendes; Isabela Lima; André Luís Pereira Silva; Washington Luiz Abreu de Jesus; Fred Luciano Neves Santos; José Guilherme Reis de Oliveira; Yscela Vanessa Pimentel de Moraes; Adijeane Oliveira de Jesus; Francisco Daltro; Ney Boa-Sorte; Humberto Castro-Lima; Maria Luísa Carvalho Soliani
Journal:  Front Med (Lausanne)       Date:  2022-06-07

Review 7.  [HTLV-1-associated myelopathy/tropical spastic paraparesis: a differential diagnosis in multiple sclerosis].

Authors:  A Liesz; S Hähnel; K Korn; M Esiri; W Hacke; B Wildemann
Journal:  Nervenarzt       Date:  2012-08       Impact factor: 1.214

8.  Detrusor Arreflexia as an End Stage of Neurogenic Bladder in HAM/TSP?

Authors:  Matheus Tannus; Davi Tanajura; Michael A Sundberg; Paulo Oliveira; Neviton Castro; André Muniz Santos
Journal:  Case Rep Med       Date:  2011-04-13

9.  Psychiatric Disorders in HTLV-1-Infected Individuals with Bladder Symptoms.

Authors:  Glória O Orge; Thais R Dellavechia; José Abraão Carneiro-Neto; Lucas Araújo-de-Freitas; Carla H C Daltro; Carlos T Santos; Lucas C Quarantini
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

10.  Intravesical injection of onabotulinumtoxinA in neurogenic overactive bladder patients with human T-cell leukemia virus type 1-associated myelopathy: A single-institution case series.

Authors:  Tomohiro Matsuo; Tatsufumi Nakamura; Katsuya Sato; Yasuyoshi Miyata; Hideki Sakai
Journal:  IJU Case Rep       Date:  2021-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.